Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Protocol for Detecting Rare and Common Genetic Associations in Whole-Exome Sequencing Studies Using MAGICpipeline

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

PedMiner: a tool for linkage analysis-based identification of disease-associated variants using family based whole-exome sequencing data

An Exome Sequencing Pipeline for Identifying and Genotyping Common CNVs Associated with Disease with Application to Psoriasis

Investigation of rare and low-frequency variants using high-throughput sequencing with pooled DNA samples

Erds-Pe: A Paired Hidden Markov Model for Copy Number Variant Detection from Whole-Exome Sequencing Data

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Pathway Analysis of Complex Diseases for GWAS, Extending to Consider Rare Variants, Multi-Omics and Interactions

Development of a coding SNP panel for tracking the origin of whole-exome sequencing samples

Application of whole exome sequencing in carrier screening for high-risk families without probands

The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities

ERDS-Exome: A Hybrid Approach for Copy Number Variant Detection from Whole-Exome Sequencing Data

A W-test collapsing method for rare variant testing with applications to exome sequencing data of hypertensive disorder

A Three-Caller Pipeline for Variant Analysis of Cancer Whole-Exome Sequencing Data

Evaluating Marginal Genetic Correlation of Associated Loci for Complex Diseases and Traits Between European and East Asian Populations.

Integrating Multiple Genomic Data to Predict Disease-Causing Nonsynonymous Single Nucleotide Variants in Exome Sequencing Studies

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

Global Inference of Disease-Causing Single Nucleotide Variants from Exome Sequencing Data

Extraction of Sequence Conservation Features for the Prioritization of Candidate Single Amino Acid Polymorphisms

Detection of Copy Number Variants and Loss of Heterozygosity from Impure Tumor Samples Using Whole Exome Sequencing Data.